Committee Decisions
Committee List
- ASPH DTC
- Commissioning Intentions
- East Surrey CCG Medicines Programme Board
- East Surrey ICP MOG
- Epsom St Helier NDAIG
- ESCCG sub-committee of North Place Alliance Clinical Strategy Committee (formerly Clinical Executive
- Guildford and Waverley MOG
- Medicines Optimisation Operational Group (MOOG)
- Not Set
- NW Surrey CCG Medicines Optimisation Group
- Primary Care Medicines Optimisation Clinical reference Group (PCMOCRG)
- RSCH DTC
- Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
- Surrey Downs CCG MOG
- Surrey Downs CCG Prescribing Leads Meeting
- Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
- Surrey Heartlands Medicines Optimisation Board (MOB)
- Surrey Heartlands Medicines Safety Committee (MSC)
- Surrey Medicines Commissioners Group
- Surrey Priorities Committee
Decisions : ASPH DTC
Records returned : 2.
Date
Drug Profile
Narrative
Traffic Light Status
Thursday, November 27, 2014
The DTC approved the use of infloran to balance and restore intestinal bacterial flora of preterm infant to reduce risk of NEC and improve feed tolerance. This will be used routinely for neonates on NICU and will be stopped prior to discharge.
Red
Thursday, November 28, 2013
The committee supported the use of nepafenac within its licensed indications. As treatment is short term postoperatively (up to 60 days with a review by the specialist 1 month post operatively) it was agreed that this would be considered as a red drug on the traffic light system.
Red